{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-006584","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2025-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.566056+00:00","generated_at":"2026-05-26T21:27:29.440711+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vivos Therapeutics enters $3.3M ATM equity offering with H.C. Wainwright","bullets":["Filed ATM offering agreement to sell up to $3,328,881 of common stock through H.C. Wainwright.","Wainwright will receive a 3% cash commission on gross sales proceeds as agent.","Offering terminates upon sale of all shares or earlier termination by either party.","Amended employment agreements for CEO Huntsman and CFO Amman effective Jan 1, 2025 (previously reported)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-006584","json":"https://secwatch.observer/filing/0001493152-25-006584.json","markdown":"https://secwatch.observer/filing/0001493152-25-006584.md","text":"https://secwatch.observer/filing/0001493152-25-006584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315225006584/0001493152-25-006584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315225006584/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T21:27:29.440711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}